» Articles » PMID: 16495246

Molecular Epidemiology of Acquired-metallo-beta-lactamase-producing Bacteria in Poland

Overview
Specialty Pharmacology
Date 2006 Feb 24
PMID 16495246
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

We have analyzed 40 metallo-beta-lactamase (MBL)-producing isolates of Pseudomonas aeruginosa (n = 38), Pseudomonas putida (n = 1), and Acinetobacter genospecies 3 (n = 1) from 17 hospitals in 12 cities in Poland that were identified in 2000 to 2004. Pulsed field gel electrophoresis typing classified the P. aeruginosa isolates into eight types, with two types differentiated further into subtypes. Each of the types was specific either to a given center or to several hospitals of the same or neighboring geographic area. Almost all of the organisms produced beta-lactamase VIM-2; the only exceptions were several P. aeruginosa isolates from two centers which expressed VIM-4. The bla(VIM) genes resided exclusively within class 1 integrons, and these were located in either chromosomal or plasmid DNA. PCR-restriction fragment length polymorphism study of the variable regions of the integrons, followed by DNA sequencing, revealed the presence of eight different, mostly novel gene cassette arrays, six of which contained bla(VIM-2) and two of which contained bla(VIM-4). The occurrence of the integron variants correlated well with the geographic distribution of the MBL-producing organisms, and this suggested that their emergence in particular parts of the country had been likely due to a number of independent events. The following regional dissemination of MBL producers could be attributed to various phenomena, including their clonal spread, horizontal transmission of resistance determinants, or both. All of the data collected in this study revealed that even at this early stage of detection, the epidemiological situation concerning MBL producers in Poland has already been complex and very dynamic.

Citing Articles

Phenotypic and molecular characterization of extended spectrum- and metallo- beta lactamase producing Pseudomonas aeruginosa clinical isolates from Egypt.

Edward E, El Shehawy M, Abouelfetouh A, Aboulmagd E Infection. 2024; 52(6):2399-2414.

PMID: 38824475 PMC: 11621155. DOI: 10.1007/s15010-024-02297-8.


Clonal Distribution and Its Association With the Carbapenem Resistance Mechanisms of Carbapenem-Non-Susceptible Isolates From Korean Hospitals.

Kim N, Ko S, Park S, Kim S, Lee D, Kwon K Ann Lab Med. 2024; 44(5):410-417.

PMID: 38433574 PMC: 11169769. DOI: 10.3343/alm.2023.0369.


Genome-Based Epidemiologic Analysis of VIM/IMP Carbapenemase-Producing Enterobacter spp., Poland.

Izdebski R, Biedrzycka M, Urbanowicz P, Zabicka D, Gniadkowski M Emerg Infect Dis. 2023; 29(8):1618-1626.

PMID: 37486192 PMC: 10370858. DOI: 10.3201/eid2908.230199.


Antimicrobial Resistance in Romania: Updates on Gram-Negative ESCAPE Pathogens in the Clinical, Veterinary, and Aquatic Sectors.

Czobor Barbu I, Gheorghe-Barbu I, Grigore G, Vrancianu C, Chifiriuc M Int J Mol Sci. 2023; 24(9).

PMID: 37175597 PMC: 10178704. DOI: 10.3390/ijms24097892.


Global Epidemiology and Mechanisms of Resistance of Acinetobacter baumannii-calcoaceticus Complex.

Castanheira M, Mendes R, Gales A Clin Infect Dis. 2023; 76(Suppl 2):S166-S178.

PMID: 37125466 PMC: 10150277. DOI: 10.1093/cid/ciad109.


References
1.
Partridge S, Hall R . In34, a complex In5 family class 1 integron containing orf513 and dfrA10. Antimicrob Agents Chemother. 2002; 47(1):342-9. PMC: 149023. DOI: 10.1128/AAC.47.1.342-349.2003. View

2.
Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo J . Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother. 2000; 44(4):891-7. PMC: 89788. DOI: 10.1128/AAC.44.4.891-897.2000. View

3.
Partridge S, Collis C, Hall R . Class 1 integron containing a new gene cassette, aadA10, associated with Tn1404 from R151. Antimicrob Agents Chemother. 2002; 46(8):2400-8. PMC: 127381. DOI: 10.1128/AAC.46.8.2400-2408.2002. View

4.
Walsh T, Toleman M, Hryniewicz W, Bennett P, Jones R . Evolution of an integron carrying blaVIM-2 in Eastern Europe: report from the SENTRY Antimicrobial Surveillance Program. J Antimicrob Chemother. 2003; 52(1):116-9. DOI: 10.1093/jac/dkg299. View

5.
Lee K, Lim J, Yum J, Yong D, Chong Y, Kim J . bla(VIM-2) cassette-containing novel integrons in metallo-beta-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital. Antimicrob Agents Chemother. 2002; 46(4):1053-8. PMC: 127086. DOI: 10.1128/AAC.46.4.1053-1058.2002. View